- Active not recruitingPHASE3
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
This study looks at a new medicine called survodutide for people who are overweight or obese. It checks if survodutide helps with heart health problems. Participants take the medicine weekly for up to 2 years, alongside diet and exercise advice.
For: ObesityUnited States · Argentina · Australia - RecruitingPHASE3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
This study looks at a new medicine called survodutide for adults with a liver condition called MASH and moderate to advanced liver damage. It aims to see if the medicine can improve liver health and how safe it is.
For: Metabolic Dysfunction Associated Steatohepatitis (MASH) · Liver FibrosisUnited States · Argentina · Australia - RecruitingPHASE3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
This study looks at a new medicine called survodutide for adults with a liver condition called NASH or MASH and scarring (cirrhosis). Participants will get either the medicine or a dummy treatment, along with diet and exercise advice, to see if it helps their liver.
For: Metabolic Dysfunction Associated SteatohepatitisUnited States · Argentina · Australia - Active not recruitingPHASE1
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
This study is looking at a new version of a medicine called survodutide, which may help people with obesity or liver conditions. We want to see how the new version is absorbed by the body in healthy people aged 18-65 with a BMI between 27 and 39.9.
For: HealthyGermany